System and method for identifying and marking a target in a fluoroscopic three-dimensional reconstruction

Information

  • Patent Grant
  • 11564649
  • Patent Number
    11,564,649
  • Date Filed
    Tuesday, December 8, 2020
    3 years ago
  • Date Issued
    Tuesday, January 31, 2023
    a year ago
Abstract
A method and system for facilitating identification and marking of a target in a displayed Fluoroscopic Three-Dimensional Reconstruction (F3DR) of a body region of a patient. The system includes a display and a storage device storing instructions for receiving an initial selection of the target in the F3DR, fining the F3DR based on the initial selection of the target, displaying the fined F3DR on the display, and receiving a final selection of the target in the fined F3DR via a user selection. The system further includes at least one hardware processor configured to execute said instructions. The method and instructions may also include receiving a selection of a medical device in two two-dimensional fluoroscopic images, where the medical device is located in an area of the target, and initially fining the F3DR based on the selection of the medical device.
Description
BACKGROUND
Technical Field

The present disclosure relates to the field of identifying and marking a target, such as a lesion or a small soft tissue object) in fluoroscopic images, 3D fluoroscopic images, fluoroscopic 3D reconstructions, or other data sets, in general, and to such target identification and marking in medical procedures involving intra-body navigation, in particular. Furthermore, the present disclosure relates to a system, apparatus, and methods of planning, navigating, identifying, marking, dying, biopsy, ablation, laparoscopy, or treatment in medical procedures.


Description of Related Art

There are several commonly applied medical methods, such as endoscopic procedures or minimally invasive procedures, for treating various maladies affecting organs including the liver, brain, heart, lung, gallbladder, kidney and bones. Often, one or more imaging modalities, such as magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), fluoroscopy as well as others are employed by clinicians to identify and navigate to areas of interest within a patient and ultimately a target for treatment. In some procedures, pre-operative scans may be utilized for target identification and intraoperative guidance. However, real-time imaging may be often required to obtain a more accurate and current image of the target area. Furthermore, real-time image data displaying the current location of a medical device with respect to the target and its surrounding may be required to navigate the medical device to the target in a more safe and accurate manner (e.g., with unnecessary or no damage caused to other organs or tissue).


For example, an endoscopic approach has proven useful in navigating to areas of interest within a patient, and particularly so for areas within luminal networks of the body such as the lungs. To enable the endoscopic approach, and more particularly the bronchoscopic approach in the lungs, endobronchial navigation systems have been developed that use previously acquired MRI data or CT image data to generate a three-dimensional (3D) rendering, model or volume of the particular body part such as the lungs.


The resulting volume generated from the MRI scan or CT scan is then utilized to create a navigation plan to facilitate the advancement of a navigation catheter (or other suitable medical device) through a bronchoscope and a branch of the bronchus of a patient to an area of interest. A locating or tracking system, such as an electromagnetic (EM) tracking system, may be utilized in conjunction with, for example, CT data, to facilitate guidance of the navigation catheter through the branch of the bronchus to the area of interest. In certain instances, the navigation catheter may be positioned within one of the airways of the branched luminal networks adjacent to, or within, the area of interest to provide access for one or more medical instruments.


However, a 3D volume of a patient's lungs, generated from previously acquired scans, such as CT scans, may not provide a basis sufficient for accurate guiding of medical instruments to a target during a navigation procedure. In certain instances, the inaccuracy is caused by deformation of the patient's lungs during the procedure relative to the lungs at the time of the acquisition of the previously acquired CT data. This deformation (CT-to-Body divergence) may be caused by many different factors including, for example, sedation vs. no sedation, bronchoscope changing patient pose and also pushing the tissue, different lung volume because CT was during inhale while navigation is during breathing, different bed, different day, etc.


Thus, another imaging modality is necessary to visualize such targets in real-time and enhance the in-vivo navigation procedure by correcting navigation during the procedure. Furthermore, in order to accurately and safely navigate medical devices to a remote target, for example, for biopsy or treatment, both the medical device and the target should be visible in some sort of a 3D guidance system.


A fluoroscopic imaging device is commonly located in the operating room during navigation procedures. The standard fluoroscopic imaging device may be used by a clinician, for example, to visualize and confirm the placement of a medical device after it has been navigated to a desired location. However, although standard fluoroscopic images display highly dense objects such as metal tools and bones as well as large soft-tissue objects such as the heart, the fluoroscopic images may have difficulty resolving small soft-tissue objects of interest such as lesions. Furthermore, the fluoroscope image is only a two-dimensional projection. Therefore, an X-ray volumetric reconstruction may enable identification of such soft tissue objects and navigation to the target.


Several solutions exist that provide 3D volume reconstruction such as CT and cone-beam CT which are extensively used in the medical world. These machines algorithmically combine multiple X-ray projections from known, calibrated X-ray source positions into 3D volume in which, inter alia, soft-tissues are more visible. For example, a CT machine can be used with iterative scans during procedure to provide guidance through the body until the tools reach the target. This is a tedious procedure, as it requires several full CT scans, a dedicated CT room and blind navigation between scans. In addition, each scan requires the staff to leave the room due to high-levels of ionizing radiation and exposes the patient to such radiation. Another option is a cone-beam CT machine, which is available in some operation rooms and is somewhat easier to operate but is expensive and like the CT only provides blind navigation between scans, requires multiple iterations for navigation and requires the staff to leave the room. In addition, a CT-based imaging system is extremely costly, and in many cases not available in the same location as the location where a procedure is carried out.


An imaging technology that uses standard fluoroscope devices to reconstruct local 3D volume in order to visualize and facilitate navigation to in-vivo targets, and to small soft-tissue objects in particular, is described in U.S. Patent Publication No. 2017/035379 to Weingarten et al., entitled SYSTEMS AND METHODS FOR LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION USING A STANDARD FLUOROSCOPE, U.S. Patent Publication No. 2017/035380 to Barak et al., entitled SYSTEM AND METHOD FOR NAVIGATING TO TARGET AND PERFORMING PROCEDURE ON TARGET UTILIZING FLUOROSCOPIC-BASED LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION, and U.S. Patent Publication No. 2018/0160991 to Weingarten et al., entitled SYSTEMS AND METHODS FOR LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION USING A STANDARD FLUOROSCOPE, the entire contents of each of which are incorporated herein by reference.


In general, according to the systems and methods disclosed in the above-mentioned patent publications, a standard fluoroscope c-arm can be rotated, e.g., about 30 degrees, around a patient during a medical procedure, and a fluoroscopic 3D reconstruction (F3DR) of the region of interest is generated by a specialized software algorithm.


Such quick generation of a 3D reconstruction of a region of interest can provide real-time 3D imaging of the target area. Real-time imaging of the target and medical devices positioned in its area may benefit numerous interventional procedures, such as biopsy and ablation procedures in various organs, vascular interventions and orthopedic surgeries. For example, when navigational bronchoscopy is concerned, the aim may be to receive accurate information about the position of a biopsy catheter relative to a target lesion.


As another example, minimally invasive procedures, such as laparoscopy procedures, including robotic-assisted surgery, may employ intraoperative fluoroscopy to increase visualization, e.g., for guidance and lesion locating, and to prevent unnecessary injury and complications. Employing the above-mentioned systems and methods for real-time reconstruction of fluoroscopic 3D imaging of a target area and for navigation based on the reconstruction may benefit such procedures as well.


Still, it may not be an easy task to accurately identify and mark a target in the F3DR, in particular when the target is a small soft-tissue. Thus, there is a need for systems and methods for facilitating the identification and marking of a target in fluoroscopic image data, and in a F3DR in particular, to consequently facilitate the navigation to the target and the yield of pertinent medical procedures.


SUMMARY

The present disclosure is directed to systems, methods and computer program products for displaying an F3DR and for facilitating the identification and marking of a target by a user in the F3DR. Marking a target in an F3DR and especially in real-time may not be straight forward or a simple task, especially for the untrained user. Furthermore, it is desired to receive a selection of the target at two capture or view angles, while at least one of them would be different than AP (anteroposterior), as selection in AP position is usually easier. Marking of the target at two such angles enhances the accuracy of the target localization. Thus, marking of the target performed at two stages, specifically when the first stage includes marking in AP position, facilitates the user's identification of the target and provides a better accuracy in the localization of the target, better registration between imaging modalities, and therefrom better results in treatment.


There is provided in accordance with the present disclosure a system for facilitating identification and marking of a target in a displayed Fluoroscopic Three-Dimensional Reconstruction (F3DR) of a body region of a patient. The system includes a display and one or more storage devices having stored thereon instructions for receiving an initial selection of the target in the F3DR, fining the F3DR based on the initial selection of the target, displaying the fined F3DR on the display, and receiving a final selection of the target in the fined F3DR via a user. The system further includes at least one hardware processor configured to execute said instructions.


In an aspect, the one or more storage devices have stored thereon further instructions for receiving a selection of a medical device in two two-dimensional fluoroscopic images, wherein the medical device is located in an area of the target, and initially fining the F3DR based on the selection of the medical device prior to fining the F3DR based on the initial selection of the target. Such a selection of the medical device may be performed prior to the selection or marking of the target. Additionally, the one or more storage devices have stored thereon further instructions for displaying the initially fined F3DR on the display and wherein the initial selection of the target is received via a user selection. The two-dimensional fluoroscopic images may be displayed on the display and the selection of the medical device in the two-dimensional fluoroscopic images may be received via a user selection.


In an aspect, the one or more storage devices have stored thereon further instructions for receiving a CT scan of the body region of the patient, wherein the CT scan includes a marking of the target, generating at least one virtual fluoroscopy image based on the CT scan, wherein the virtual fluoroscopy image includes the target and the marking of the target, and displaying the virtual fluoroscopy image. Displaying the fined F3DR may include displaying different slices of the fined F3DR and may be according to commands provided by the user such as a user selection. Additionally, or alternatively, displaying the fined F3DR includes displaying the fined F3DR at different capture angles and may be according to commands provided by the user such as a user selection.


Receiving of the final selection of the target in the fined F3DR may include directing the user to identify and mark the target in two fluoroscopic slice images of the fined F3DR captured at two different angles. Additionally, or alternatively, receiving of the final selection of the target in the fined F3DR may include indicating proper ranges of capture angles in which the target should be marked. In an aspect, the target is a soft-tissue target.


In an aspect, the system further includes a fluoroscopic imaging device and the one or more storage devices have stored thereon further instructions for acquiring a sequence of fluoroscopic images of the body region about a plurality of angles relative to the body region while a medical device is positioned in a target area, generating the F3DR of the body region based on the sequence of fluoroscopic images, and determining an offset of the medical device with respect to the target based on the selection of the medical device and at least one of the initial selection of the target or the final selection of the target. The target area may include at least a portion of lungs and the medical device may be configured to be navigated to the target area through a luminal network of lungs.


In an aspect, the one or more storage devices have stored thereon further instructions for receiving a three-dimensional imaging of the body region of the patient, wherein the three-dimensional imaging includes a marking of the target, and displaying the three-dimensional imaging. The three-dimensional imaging may be a CT or an MRI scan.


In an aspect, the system is used during a medical procedure, and the three-dimensional imaging is a pre-operative imaging which was used in a planning phase of the medical procedure.


In another aspect of the present disclosure a method for facilitating identification and marking of a target in a displayed F3DR of a body region of a patient is provided. The method includes using at least one hardware processor for receiving an initial selection of the target in the F3DR, fining the F3DR based on the initial selection of the target, displaying the fined F3DR on a display, and receiving a final selection of the target in the fined F3DR via a user.


In an aspect, the method includes using said at least one hardware processor for receiving a selection of a medical device in two two-dimensional fluoroscopic images, where the medical device is located in an area of the target, and initially fining the F3DR based on the selection of the medical device. Additionally, or alternatively, the method further includes at least one hardware processor for displaying the initially fined F3DR on the display, wherein the initial selection of the target is received via a user selection. In an aspect, the method further includes using said at least one hardware processor for displaying the two-dimensional fluoroscopic images on the display, wherein the selection of the medical device in the two-dimensional fluoroscopic images is received via a user selection.


In an aspect, the method includes using the at least one hardware processor for receiving a CT scan of the body region of the patient, wherein the CT scan includes a marking of the target, generating at least one virtual fluoroscopy image based on the CT scan, wherein the virtual fluoroscopy image includes the target and the marking of the target, and displaying the virtual fluoroscopy image on the display. Displaying of the virtual fluoroscopy image may be performed upon a user's request. Displaying of the fined F3DR may include displaying different slices of the fined F3DR and may be according to commands provided by the user such as a user selection. Additionally, or alternatively, displaying of the fined F3DR includes displaying the fined F3DR at different capture angles and may be according to commands provided by the user such as a user selection.


In an aspect, receiving of the final selection of the target in the fined F3DR includes directing the user to identify and mark the target in two fluoroscopic slice images of the fined F3DR captured at two different angles. Additionally, or alternatively, receiving of the final selection of the target in the fined F3DR includes indicating proper ranges of capture angles in which the target should be marked.


In an aspect, the method further includes using the at least one hardware processor for acquiring a sequence of fluoroscopic images of the body region via a fluoroscopic imaging device and about a plurality of angles relative to the body region, generating the F3DR of the body region based on the sequence of fluoroscopic images, and determining an offset of a medical device with respect to the target based on the selections of the target and the medical device, thereby facilitating navigation to an area of the target within the patient's body region during a medical procedure using real-time two-dimensional fluoroscopic images. Additionally, or alternatively, the method includes using the at least one hardware processor for receiving a three-dimensional imaging of the body region of the patient, wherein the three-dimensional imaging includes a marking of the target, and displaying the three-dimensional imaging.


The method may be used during a medical procedure, and the three-dimensional imaging is a pre-operative imaging which was used in a planning phase of the medical procedure.


In yet another aspect of the present disclosure, a non-transitory computer-readable storage medium encoded with a program that, when executed by a processor, performs a method for facilitating identification and marking of a target in a F3DR of a body region of a patient is provided. The method includes receiving a selection of a medical device in two two-dimensional fluoroscopic images, where the medical device is located in an area of the target, initially fining the F3DR based on the selection of the medical device, displaying the initially fined F3DR on a display, receiving an initial selection of the target in the initially fined F3DR via a user selection, further fining the F3DR based on the initial selection of the target, displaying the further fined F3DR on the display, and receiving a final selection of the target in the further fined F3DR via a user selection, thereby facilitating an identification and marking of the target in the F3DR.





BRIEF DESCRIPTION OF THE DRAWINGS

Various aspects and embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:



FIG. 1 is a flow chart of a method for displaying a F3DR and for identifying and marking a target in the F3DR in accordance with the present disclosure;



FIG. 2 is a schematic diagram of a system configured for use with the method of FIG. 1;



FIG. 3A is an exemplary screen shot showing a display of a F3DR in accordance with the present disclosure;



FIG. 3B is an exemplary screen shot showing an initial selection of a target in the F3DR of FIG. 3A;



FIG. 3C is an exemplary screen shot showing a display of a virtual fluoroscopy image showing a previous selection of a target (for example, a previous selection of the target performed in a planning phase) in accordance with the present disclosure;



FIG. 3D is an exemplary screen shot showing a display of a fined F3DR in accordance with the present disclosure;



FIG. 3E is an exemplary screen shot of a final selection of the target in a slice image of the fined F3DR while captured at a first capture angle in accordance with the present disclosure;



FIG. 3F is an exemplary screen shot of a final selection of the target in a slice image of the fined F3DR while captured at a first capture angle and a second capture angle in accordance with the present disclosure;



FIG. 4A is an exemplary screen shot showing a selection of a medical device in two two-dimensional fluoroscopic images in accordance with the present disclosure;



FIG. 4B is an exemplary screen shot showing a first selection of a target in an initially fined F3DR in accordance with the present disclosure;



FIG. 4C is an exemplary screen shot showing a display of the initially fined F3DR and of slice images of a CT scan in accordance with the present disclosure;



FIG. 4D is an exemplary screen shot showing a display of a virtual fluoroscopy image and of the slice images of a CT scan in accordance with the present disclosure;



FIG. 4E is an exemplary screen shot showing a display of the fined F3DR in accordance with the present disclosure; and



FIG. 4F is an exemplary screen shot showing a clip of the F3DR for confirming the selection of the target in accordance with the present disclosure.





DETAILED DESCRIPTION

The term “target”, as referred to herein, may relate to any element, biological or artificial, or to a region of interest in a patient's body, such as a tissue (including soft tissue and bone tissue), an organ, an implant or a fiducial marker.


The term “target area”, as referred to herein, may relate to the target and at least a portion of its surrounding area. The term “target area” and the term “body region” may be used interchangeably when the term “body region” refers to the body region in which the target is located. Alternatively or in addition, the term “target area” may also refer to a portion of the body region in which the target is located, all according to the context.


The terms “and”, “or” and “and/or” may be used interchangeably, while each term may incorporate the others, all according to the term's context.


The term “medical device”, as referred to herein, may include, without limitation, optical systems, ultrasound probes, marker placement tools, biopsy tools, ablation tools (i.e., microwave ablation devices), laser probes, cryogenic probes, sensor probes, and aspirating needles.


The terms “fluoroscopic image”, “fluoroscopic images”, “fluoroscopy image”, and “fluoroscopy images” may refer to a 2D fluoroscopic image/s and/or to a slice-image of a fluoroscopic 3D reconstruction, all in accordance with the term's context.


The terms “virtual fluoroscopic image”, “virtual fluoroscopic images”, “virtual fluoroscopy image”, and “virtual fluoroscopy images” may refer to a virtual 2D fluoroscopic image/s and/or to a virtual fluoroscopy slice-image/s of a virtual fluoroscopic 3D reconstruction, or other 3D image data all in accordance with the term's context.


The present disclosure is directed to systems, methods and computer program products for displaying an F3DR and for facilitating the identification and marking of a target by a user in the F3DR. Marking a target in an F3DR and especially in real-time may not be straight forward or a simple task, especially for the untrained user. Furthermore, it is desired to receive a selection of the target at multiple capture or view angles (for example, two or three capture angles), while at least one of them would be different than AP (anteroposterior), as selection in AP position is usually easier. Marking of the target at two such angles enhances the accuracy of the target localization. Thus, marking of the target performed at two stages, specifically when the first stage includes marking in AP position, facilitates the user's identification of the target and provides a better accuracy in the localization of the target, better registration between imaging modalities, and therefrom better results in treatment.


In addition, using the initial target selection (e.g., at the first stage) to fine the F3DR further facilitates the final selection (e.g., at two different angles) and enhances its accuracy. Optionally, the process may be further enhanced by performing a two-stage fining of the F3DR by using a selection or marking of a medical device located in the target area to initially fine the F3DR.


Reference is now made to FIG. 1, which is a flow chart of a method for displaying a F3DR of a body region of a patient and for identifying and marking a target in the F3DR in accordance with the present disclosure. In some embodiments, that target may be a soft tissue target, such as a lesion and the body region may include at least a portion of the lungs. The method may begin either at step 100 or at step 120. To this end, steps 100 and 110 are optional steps. In step 100, a selection of a medical device in one or more fluoroscopy images or in a F3DR is received. Such a selection may be made from a single capture angle or from multiple capture angles. Additionally, the selection of the medical device in step 100 may be automatically made by the system via a dedicated algorithm or may be made by a user's selection. In an aspect, the selection of the medical device is performed in 2D fluoroscopic images, in particular, in at least two images. In an aspect, the medical device is marked or selected before the generation of the F3DR and the marking may be used for the generation/reconstruction of the F3DR.


In step 110, the F3DR is initially fined based on the received selection of the medical device in step 100. The initial fining of the F3DR in step 100 may include determining a range for the slice scrolling. In this aspect, the range is determined such that only a portion of the F3DR, which includes the selection of the medical device, is displayed and may be scrolled through. Thus, in this aspect, less slices are displayed to the user. One benefit of fining in this manner is that less slices are processed (e.g., fined), thereby reducing the use of computing resources and speeding the fining process. Additionally, or alternatively, the F3DR may be initially fined by decreasing the thickness of the slices thus achieving a better resolution for display. One benefit of fining in this manner is that a user may be presented with sharpened slices, thereby offering a better visualization of the target area and objects (e.g., medical devices, targets, etc.) located therein.


In an aspect, the thickness of the slices is predetermined. Although thinning the slices provides a better resolution, there may be a toll on thinning. That is, when slices are thinned, the volume appears more smeared and thus it becomes more difficult for the user to identify the target. Therefore, at the initial fining (step 110), a predetermined thickness is used which provides optimal results, taking into consideration the above. At the second stage, as described below (in step 130), the scroll range is decreased, the thickness of the slices is decreased, again to a predetermined thickness, or both the scroll range is decreased and the thickness of the slices is decreased.


In step 120, an initial selection of the target in the F3DR is received. As described above, in aspects, this method begins at step 120 and the initial selection of the target is made in the F3DR. Alternatively, where the method begins at step 100, the initial selection of the target in step 120 is made in the initially fined F3DR (as initially fined in step 110). The initial selection of the target may be automatic via a dedicated algorithm or may be performed by a user's selection, e.g., by identifying and marking the target in the displayed F3DR.


Reference is now briefly made to FIGS. 3A-3B, which are screen shots of a user interface, which facilitates the selection of a target in an F3DR. FIG. 3A is an exemplary screen shot 300a showing a display of the F3DR and a scrolling bar 302 in accordance with the present disclosure. FIG. 3B is an exemplary screen shot 300b, showing an initial selection of the target “T” in the F3DR of FIG. 3A. The F3DR in this example is shown in AP position (anteroposterior) and includes slice images 305 through which the user may scroll by using a scroll bar 302. The thickness of the slice images 305 may be predetermined (e.g., number of pixels). In an aspect, the slice images 305 are slices of the F3DR. The user may then identify the target T in one of the slice images 305 and mark it, for example, by using a circular marking. For further convenience, an additional image 307 of the marked target T may be displayed, e.g., in a window adjacent to the F3DR. The additional image 307 may be any image including but not limited to a zoom-in image, a cropped image, a stretched image, or any combinations thereof. The aim is to mark the target T in the slice image 305 that displays it best or in a good enough visibility. To assist in this respect, the method includes the step of fining the image as described in further detail below.


In step 130, the F3DR (or the initially fined F3DR as initially fined in step 110) is fined based on the initial selection of the target. The F3DR may be fined by determining a range for the slice scrolling. The range is determined such that only a portion of the F3DR, which includes the marked target, is displayed and may be scrolled through. Thus, in this aspect, less slices are displayed to the user. One benefit of fining in this manner is that less slices are processed (e.g., fined), thereby reducing the use of computing resources and speeding the fining process. Additionally, or alternatively, the F3DR may be fined by decreasing the thickness of the slices thus achieving a better resolution for display. One benefit of fining in this manner is that a user may be presented with sharpened slices, thereby offering a better visualization of the target area and objects (e.g., medical devices, targets, etc.) located therein. As described above, at the second stage (in step 130), the scroll range is decreased, the thickness of the slices is decreased, again to a predetermined thickness, or both the scroll range is decreased and the thickness of the slices is decreased.


In step 140, the fined F3DR is displayed on a display. In some embodiments, the display of the fined F3DR may include displaying different slices of the fined F3DR and may be displayed according to commands provided by the user, e.g., through a slices scroll bar as shown in FIGS. 3A and 3B. In some embodiments, the display of the fined F3DR may include displaying the fined F3DR at different capture angles and according to commands provided by the user.


Reference is now made to FIG. 3D, which is an exemplary screen shot 300d showing a display of a fined F3DR 370 in accordance with the present disclosure. The display of the screen shot 300d includes the fined F3DR 370, the slices scroll bar 302 and a capture angle scroll bar 303, which allows the user to control the angle at which the fined F3DR 370 is displayed. By “capture angle” it is meant the angle at which the F3DR or fined F3DR 370 is captured or viewed.


In step 150, a final selection of the target T in the fined F3DR is received via a user. In some embodiments, the receiving of the final selection of the target may include directing the user to identify and mark the target or select the target in a single fluoroscopic (or F3DR) slice image. In some embodiments, the receiving of the final selection of the target may include directing the user to identify and mark the target or select the target in two fluoroscopic slice images of the fined F3DR captured at two different angles. Identifying and marking the target or selecting the target in two or more slice images captured at different angles, as opposed to one, may enhance the localization of the target to achieve a better accuracy, e.g., by using triangulation. Thus, the target may be located within the slice image (which has a certain thickness). In some embodiments, the receiving of the final selection of the target in the fined F3DR in step 150 may further include indicating the proper ranges of capture angles in which the target should be marked. In some embodiments, the selection of the slices may be limited to such proper ranges of capture angles. The proper ranges of the two capture angles may be determined to provide enough distance between the two angles to achieve a good enough accuracy in the target localization within the F3DR.


Displaying the fined F3DR, e.g., a portion of the F3DR surrounding the initially identified target, in step 140 may facilitate the selection of the target (for example in step 150). Specifically, it may facilitate the selection of the target in two slices captured at different angles. Selection of the target in two such slices may be more time consuming and may be more difficult than, for example, selecting the target when the F3DR is positioned in AP.


Reference is now made to FIGS. 3E and 3F. FIG. 3E is an exemplary screen shot 300e of a final selection of the target T in a slice image 321 of the fined F3DR while captured at a first capture angle in accordance with the present disclosure. FIG. 3F is an exemplary screen shot 300f of a final selection of the target T in a slice image 321 of the fined F3DR 370 while captured at a first capture angle and a second capture angle in accordance with the present disclosure. According to the exemplary user interface shown in FIGS. 3E and 3F, the user may mark a target T, which is shown only in slices 321 in the delimited areas of the capture angles scroll bar 303. When the user marks a target T, a close-up image of the marked target is displayed in a window for each of the first capture angle and the second capture angle. As shown in the exemplary screen shot 300f of FIG. 3F, a first window 323 is displayed with the target T at the first capture angle and a second window 325 is displayed with the target T at the second capture angle.


As described above with reference to steps 100 and 110, in some embodiments, a selection of a medical device in two two-dimensional (2D) fluoroscopic images may be received, where the medical device is located in the area of the target. The F3DR may be then initially fined based on the selection of the medical device. The 2D fluoroscopic images may be related to the F3DR via their capture angles. The initial selection of the target may be then performed in the initially fined F3DR, thus facilitating the initial selection of the target. In some embodiments, the two-dimensional fluoroscopic images may be displayed on the display and the selection of the medical device may be received via automatic detection algorithms or via the user's selection. In some embodiments, the initially fined F3DR may be displayed on the display and the initial selection of the target may be received via the user's selection.


Reference is now made to FIGS. 4A-4F, which are screen shots of another user interface that facilitates the selection of a target in an F3DR. FIG. 4A is an exemplary screen shot 400a showing a selection of a catheter “C” in two two-dimensional fluoroscopic images, namely first two-dimensional fluoroscopic image 401 and second two-dimensional fluoroscopic image 402, in accordance with the present disclosure. FIG. 4B is an exemplary screen shot 400b showing a first selection of a target T in an initially fined F3DR 470, in accordance with the present disclosure.


In some embodiments, a CT scan of the body region of the patient, which includes a marking of the target, may be received. At least one virtual fluoroscopy image, for example, virtual fluoroscopy image 350 (FIG. 3C) or virtual fluoroscopy image 450 (FIG. 4D), which includes the target and the marking of the target may be generated based on the CT scan. The virtual fluoroscopy image may be then displayed on the display and may be used by the user as a reference when selecting the target in the F3DR (e.g., when performing an initial and/or final selection of the target). In some embodiments, the virtual fluoroscopy image may be displayed upon the user's request. In some embodiments, the virtual fluoroscopy image and the F3DR may be displayed simultaneously. In other embodiments, the virtual fluoroscopy image and the F3DR may be displayed alternatively. Further details with respect to the display, generation and use of the virtual fluoroscopy image are described in U.S. patent application Ser. No. 16/022,222 to Weingarten et al., entitled SYSTEM AND METHOD FOR IDENTIFYING, MARKING AND NAVIGATING TO A TARGET USING REAL TIME TWO DIMENSIONAL FLUOROSCOPIC DATA, the entire contents of which are incorporated herein by reference.


Reference is now made to FIG. 3C, which is an exemplary screen shot 300c showing a display of a virtual fluoroscopy image 350 in accordance with the present disclosure. According to the example shown in FIG. 3A-3F, the virtual fluoroscopy image 350 is displayed upon the user's request or command, e.g., by pressing a “Planned Target” button, and may be displayed at any stage of the target selection. In this example, the virtual fluoroscopy image 350 is displayed instead of the F3DR, but it is appreciated that the virtual fluoroscopy image 350 may be displayed along with (e.g., adjacent) the displayed F3DR.


In some embodiments, the method may further include acquiring the sequence of fluoroscopic images of the body region via a fluoroscopic imaging device and about a plurality of angles relative to the body region. The F3DR may be then generated based on the sequence of fluoroscopic images. An offset of the medical device with respect to the target may be determined based on the selections of the target and the medical device. Such offset determination based on two-dimensional fluoroscopic images captured in real-time may be used to facilitate navigation to an area of the target during a medical procedure. The real-time target-medical-device offset may be used, for example and without limitation, to correct navigation (e.g., displayed or calculated positions of a catheter) and generate local F3DR-CT scan registration. In some embodiments, the target area may include at least a portion of the lungs and the medical device is configured to be navigated to the target area through the airway's luminal network. Generation of such an F3DR and the uses of the above offset are described in U.S. Patent Publication No. 2017/035379 to Weingarten et al., entitled SYSTEMS AND METHODS FOR LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION USING A STANDARD FLUOROSCOPE, U.S. Patent Publication No. 2017/035380 to Barak et al., entitled SYSTEM AND METHOD FOR NAVIGATING TO TARGET AND PERFORMING PROCEDURE ON TARGET UTILIZING FLUOROSCOPIC-BASED LOCAL THREE DIMENSIONAL VOLUME RECONSTRUCTION, and provisional U.S. Patent Application No. 62/628,017 to Barak et al., entitled SYSTEM AND METHOD FOR POSE ESTIMATION OF AN IMAGING DEVICE AND FOR DETERMINING THE LOCATION OF A MEDICAL DEVICE WITH RESPECT TO A TARGET, the entire contents of each of which are incorporated herein by reference.


In some embodiments, the method may further include receiving three-dimensional (3D) imaging of the body region of the patient, which includes a marking of the target. The 3D imaging may be, for example, a CT scan or an MRI scan data set. The 3D imaging may be then displayed. The 3D imaging may be used by the user as a reference when performing an initial and/or final selection of the target. Utilizing a 3D view of the target for identifying the target in another 3D view, e.g., the F3DR, may be advantageous. The 3D imaging may be displayed upon the user's request or command. The 3D imaging and the F3DR and/or a virtual fluoroscopy image may be displayed simultaneously and/or alternatively. In some embodiments, when the disclosed methods are used during a medical procedure (e.g., identifying a target via real-time fluoroscopic 3D images), a pre-operative 3D imaging data set, which was used in a planning phase of the procedure may be used. Using images, e.g., which were used for identifying the target and planning the navigation to the target, may be very advantageous in performing identification and marking (e.g., selection) of the target in a real-time three-dimensional volume, reconstruction or rendering.


Reference is now made to FIGS. 4C-4E. FIG. 4C is an exemplary screen shot 400c showing a display of the initially fined F3DR 470 and of slice images 460 of a CT scan in accordance with the present disclosure. In this specific example, the slice images 460 of the CT scan may be displayed upon the user's command. The CT scan is displayed by displaying three views of the CT (e.g., axial, coronal and sagittal) which may provide the user with the option to create a 3D mental image of the target area that can help in identifying the target in the real-time F3DR. The default slices displayed in FIG. 4C are the slices at which the user marked the target at the planning phase of a medical procedure. The user may scroll or page through the slices. Additionally, the user may select an enlarge button to enlarge any of the slice images 460 for a more detailed view of the displayed slice. In some embodiments, other views of the CT used in the planning phase may be displayed.



FIG. 4D is an exemplary screen shot 400d showing a display of a virtual fluoroscopy image 450 and of the slice images 460 of a CT scan in accordance with the present disclosure. In this example, the virtual fluoroscopy image 450 is displayed instead of the F3DR and is displayed adjacent to the slice images 460 of the CT scan. FIG. 4E is an exemplary screen shot 400e showing a display of the fined F3DR 471 in accordance with the present disclosure.


In some embodiments, after the final selection of the target is performed, the target as selected may be displayed to the user and the user may be requested to confirm the selection. Reference is now made to FIG. 4F, which is an exemplary screen shot 400f showing a clip 470 of the F3DR for confirming the selection of the target T in accordance with the present disclosure. The F3DR including the marking of the target T (e.g., a circular marking) and optionally a marking of the catheter (e.g., a plus or cross-hair marking) may be displayed. In order to further confirm the selection, a clip 470 may be displayed which shows the F3DR with the markings at the different capture angles (e.g., the angles at which the 2D fluoroscopic images used to generate the F3DR were captured).


A computer program product for displaying a F3DR and for identifying, marking and navigating to a target is herein disclosed. The computer program product may include a non-transitory computer-readable storage medium having program code embodied therewith. The program code may be executable by at least one hardware processor to perform the steps of the method of FIG. 1 and as disclosed herein above.


Reference is now made to FIG. 2, which is a schematic diagram of a system 200 configured for use with the method of FIG. 1 and as described herein above. System 200 may include a workstation 80, and optionally a fluoroscopic imaging device or fluoroscope 215. In some embodiments, workstation 80 may be coupled with fluoroscope 215, directly or indirectly, e.g., by wireless communication. Workstation 80 may include memory 202 (e.g., storage device), a processor 204, a display 206 and an input device 210. Processor or hardware processor 204 may include one or more hardware processors. Workstation 80 may optionally include an output module 212 and a network interface 208. Memory 202 may store an application 81 and image data 214. Application 81 may include instructions executable by processor 204, inter alia, for executing the method steps of FIG. 1 and as described herein above. Application 81 may further include a user interface 216. Image data 214 may include the 3D imaging such as a pre-operative CT scan, the F3DRs of the target area and/or any other fluoroscopic image data and/or one or more virtual fluoroscopy images. Processor 204 may be coupled with memory 202, display 206, input device 210, output module 212, network interface 208 and imaging device (e.g., fluoroscope 215). Workstation 80 may be a stationary computing device, such as a personal computer, or a portable computing device such as a tablet computer. Workstation 80 may embed a plurality of computer devices.


Memory 202 may include any non-transitory computer-readable storage media for storing data and/or software including instructions that are executable by processor 204 and which control the operation of workstation 80 and in some embodiments, may also control the operation of fluoroscope 215. Fluoroscope 215 may be used to capture a sequence of fluoroscopic images based on which the F3DR is generated. The two-dimensional fluoroscopic images in which the medical device is selected may be selected from the captured sequence of fluoroscopic images. In an embodiment, storage device or memory 202 may include one or more storage devices such as solid-state storage devices such as flash memory chips. Alternatively, or in addition to the one or more solid-state storage devices, memory 202 may include one or more mass storage devices connected to the processor 204 through a mass storage controller (not shown) and a communications bus (not shown). Although the description of computer-readable media contained herein refers to a solid-state storage, it should be appreciated by those skilled in the art that computer-readable storage media can be any available media that can be accessed by the processor 204. That is, computer readable storage media may include non-transitory, volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data. For example, computer-readable storage media may include RAM, ROM, EPROM, EEPROM, flash memory or other solid-state memory technology, CD-ROM, DVD, Blu-Ray or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store the desired information, and which may be accessed by workstation 80.


Application 81 may, when executed by processor 204, cause display 206 to present user interface 216. User interface 216 may be configured to present to the user the F3DR, two-dimensional fluoroscopic images, images of the 3D imaging and virtual fluoroscopy image, as shown, for example, in the exemplary screen shots of FIGS. 3A-3F and 4A-4F. User interface 216 may be further configured to direct the user to select the target by, inter alia, identifying and marking the target in the displayed F3DR or any other fluoroscopic image data in accordance with the present disclosure.


Network interface 208 may be configured to connect to a network such as a local area network (LAN) consisting of a wired network and/or a wireless network, a wide area network (WAN), a wireless mobile network, a Bluetooth network, and/or the internet. Network interface 208 may be used to connect between workstation 80 and fluoroscope 215. Network interface 208 may be also used to receive image data 214. Input device 210 may be any device by means of which a user may interact with workstation 80, such as, for example, a mouse, keyboard, foot pedal, touch screen, and/or voice interface. Output module 212 may include any connectivity port or bus, such as, for example, parallel ports, serial ports, universal serial busses (USB), or any other similar connectivity port known to those skilled in the art.


From the foregoing and with reference to the various figure drawings, those skilled in the art will appreciate that certain modifications can also be made to the present disclosure without departing from the scope of the same.


Detailed embodiments of the present disclosure are disclosed herein. However, the disclosed embodiments are merely examples of the disclosure, which may be embodied in various forms and aspects. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present disclosure in virtually any appropriately detailed structure.


While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims
  • 1. A system for facilitating identification and marking of a target in a displayed Fluoroscopic Three-Dimensional Reconstruction (F3DR) of a body region of a patient, the system comprising: (i) a display;(ii) one or more storage devices having stored thereon instructions for: acquiring a sequence of fluoroscopic images of the body region about a plurality of angles relative to the body region while a medical device is positioned in a target area;generating the F3DR of the body region based on the sequence of fluoroscopic images;receiving a selection of a medical device in two two-dimensional fluoroscopic images from the sequence of fluoroscopic images;receiving an initial selection of the target in the F3DR;determining a range of fluoroscopic slices of the F3DR for slice scrolling based on the initial selection of the target or the medical device;displaying one or more fluoroscopic slice images from the determined range of fluoroscopic slices of the F3DR on the display;receiving a final selection of the target in at least one of the fluoroscopic slices from the determined range of fluoroscopic slices of the F3DR via a user selection, anddetermining an offset of the medical device with respect to the target based on the selection of the medical device and at least one of the initial selection of the target or the final selection of the target;generating a local F3DR-computed tomography (CT) scan registration; and(iii) at least one hardware processor configured to execute said instructions.
  • 2. The system of claim 1, wherein the one or more storage devices have stored thereon further instructions for: determining the range of slices based on the selection of the medical device prior to initial selection of the target.
  • 3. The system of claim 1, wherein the one or more storage devices have stored thereon further instructions for: receiving a computed tomography (CT) scan of the body region of the patient,
  • 4. The system of claim 1, wherein displaying one or more fluoroscopic slice images from the determined range of fluoroscopic slices of the F3DR on the display comprises displaying different slices of the F3DR according to commands provided by the user.
  • 5. The system of claim 1, wherein displaying one or more fluoroscopic slice images from of the determined range of fluoroscopic slices of the F3DR on the display comprises displaying the one or more slices at different capture angles according to commands provided by the user.
  • 6. The system of claim 1, wherein the receiving of the final selection of the target in at least one of the fluoroscopic slices of the F3DR comprises directing the user to identify and mark the target in two slices of the F3DR captured at two different angles.
  • 7. The system of claim 1, wherein a thickness of a fluoroscopic slice from the determined range of fluoroscopic slices of the F3DR is reduced to achieve better resolution.
  • 8. The system of claim 7, wherein the target area comprises at least a portion of lungs and the medical device is configured to be navigated to the target area through a luminal network of lungs.
  • 9. The system of claim 1, wherein the one or more storage devices have stored thereon further instructions for: receiving a three-dimensional imaging of the body region of the patient, wherein the three-dimensional imaging includes a marking of the target; anddisplaying the three-dimensional imaging.
  • 10. The system of claim 9, wherein the three-dimensional imaging is a computed tomography (CT) or a magnetic resonance image (MRI) scan.
  • 11. A method for facilitating identification and marking of a target in a Fluoroscopic Three-Dimensional Reconstruction (F3DR) of a body region of a patient, the method comprising using at least one hardware processor for: acquiring a sequence of fluoroscopic images of the body region about a plurality of angles relative to the body region while a medical device is positioned in a target area;generating the F3DR of the body region based on the sequence of fluoroscopic images;receiving a selection of a medical device in two two-dimensional fluoroscopic images from the sequence of fluoroscopic images;receiving an initial selection of the target in the F3DR;determining a range of fluoroscopic slices of the F3DR for slice scrolling based on the initial selection of the target or the medical device;displaying one or more fluoroscopic slice images from the determined range of fluoroscopic slices of the F3DR on the display;receiving a final selection of the target in at least one of the fluoroscopic slices from the determined range of fluoroscopic slices of the F3DR via a user selection, anddetermining an offset of the medical device with respect to the target based on the selection of the medical device and at least one of the initial selection of the target or the final selection of the target; andgenerating a local F3DR-computed tomography (CT) scan registration.
  • 12. The method of claim 11, further comprising using said at least one hardware processor for: determining the range of fluoroscopic slices based on the selection of the medical device prior to initial selection of the target.
  • 13. The method of claim 11, further comprising using said at least one hardware processor for: receiving a computed tomography (CT) scan of the body region of the patient,
  • 14. The method of claim 11, wherein displaying one or more fluoroscopic slice images from the determined range of fluoroscopic slices of the F3DR on the display comprises displaying different slices of the F3DR according is performed upon a user's request.
  • 15. The method of claim 11, wherein the displaying one or more fluoroscopic slice images from of the determined range of slices of the F3DR on the display comprises displaying the one or more slices at different capture angles according to commands provided by the user.
  • 16. The method of claim 11, wherein the receiving of the final selection of the target in at least one of the fluoroscopic slices of the F3DR comprises directing the user to identify and mark the target in two fluoroscopic slices of the F3DR captured at two different angles.
  • 17. The method of claim 11 wherein a thickness of the fluoroscopic slices from the determined range of slices of the F3DR is reduced to achieve better resolution.
  • 18. The method of claim 11, wherein the target area comprises at least a portion of lungs and the medical device is configured to be navigated to the target area through a luminal network of lungs.
  • 19. The method of claim 11, further comprising using said at least one hardware processor for: receiving a three-dimensional imaging of the body region of the patient, wherein the three-dimensional imaging includes a marking of the target; anddisplaying the three-dimensional imaging.
  • 20. The method of claim 19, wherein the method is used during a medical procedure, and wherein the three-dimensional imaging is a pre-operative imaging which was used in a planning phase of the medical procedure.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/156,650 filed Oct. 10, 2018, which claims the benefit of the filing dates of provisional U.S. Patent Application No. 62/570,431, filed Oct. 10, 2017, provisional U.S. Patent Application No. 62/641,777, filed Mar. 12, 2018, and provisional U.S. Patent Application No. 62/628,017, filed Feb. 8, 2018, the entire contents of each of which are incorporated herein by reference.

US Referenced Citations (377)
Number Name Date Kind
5057494 Sheffield Oct 1991 A
5321113 Cooper et al. Jun 1994 A
5706324 Wiesent et al. Jan 1998 A
5852646 Klotz et al. Dec 1998 A
5930329 Navab Jul 1999 A
5951475 Gueziec et al. Sep 1999 A
5963612 Navab Oct 1999 A
5963613 Navab Oct 1999 A
6003517 Sheffield et al. Dec 1999 A
6038282 Wiesent et al. Mar 2000 A
6049582 Navab Apr 2000 A
6050724 Schmitz et al. Apr 2000 A
6055449 Navab Apr 2000 A
6081577 Webber Jun 2000 A
6118845 Simon et al. Sep 2000 A
6120180 Graumann Sep 2000 A
6236704 Navab et al. May 2001 B1
6243439 Arai et al. Jun 2001 B1
6285739 Rudin et al. Sep 2001 B1
6289235 Webber et al. Sep 2001 B1
6317621 Graumann et al. Nov 2001 B1
6351513 Bani-Hashemi et al. Feb 2002 B1
6359960 Wahl et al. Mar 2002 B1
6373916 Inoue et al. Apr 2002 B1
6382835 Graumann et al. May 2002 B2
6389104 Bani-Hashemi et al. May 2002 B1
6404843 Vaillant Jun 2002 B1
6424731 Launay et al. Jul 2002 B1
6473634 Barni Oct 2002 B1
6484049 Seeley et al. Nov 2002 B1
6485422 Mikus et al. Nov 2002 B1
6490475 Seeley et al. Dec 2002 B1
6491430 Seissler Dec 2002 B1
6493575 Kesten et al. Dec 2002 B1
6546068 Shimura Apr 2003 B1
6546279 Bova et al. Apr 2003 B1
6549607 Webber Apr 2003 B1
6585412 Mitschke Jul 2003 B2
6662036 Cosman Dec 2003 B2
6666579 Jensen Dec 2003 B2
6697664 Kienzle et al. Feb 2004 B2
6707878 Claus et al. Mar 2004 B2
6714810 Grzeszczuk et al. Mar 2004 B2
6731283 Navab May 2004 B1
6731970 Schlossbauer et al. May 2004 B2
6768784 Green et al. Jul 2004 B1
6782287 Grzeszczuk et al. Aug 2004 B2
6785356 Grass et al. Aug 2004 B2
6785571 Glossop Aug 2004 B2
6801597 Webber Oct 2004 B2
6810278 Webber et al. Oct 2004 B2
6823207 Jensen et al. Nov 2004 B1
6851855 Mitschke et al. Feb 2005 B2
6856826 Seeley et al. Feb 2005 B2
6856827 Seeley et al. Feb 2005 B2
6865253 Blumhofer et al. Mar 2005 B2
6898263 Avinash et al. May 2005 B2
6912265 Hebecker et al. Jun 2005 B2
6928142 Shao et al. Aug 2005 B2
6944260 Hsieh et al. Sep 2005 B2
6956927 Sukeyasu et al. Oct 2005 B2
7010080 Mitschke et al. Mar 2006 B2
7010152 Bojer et al. Mar 2006 B2
7035371 Boese et al. Apr 2006 B2
7048440 Graumann et al. May 2006 B2
7066646 Pescatore et al. Jun 2006 B2
7106825 Gregerson et al. Sep 2006 B2
7117027 Zheng et al. Oct 2006 B2
7129946 Ditt et al. Oct 2006 B2
7130676 Barrick Oct 2006 B2
7142633 Eberhard et al. Nov 2006 B2
7147373 Cho et al. Dec 2006 B2
7165362 Jobs et al. Jan 2007 B2
7186023 Morita et al. Mar 2007 B2
7251522 Essenreiter et al. Jul 2007 B2
7327872 Vaillant et al. Feb 2008 B2
7343195 Strommer et al. Mar 2008 B2
7369641 Tsubaki et al. May 2008 B2
7426256 Rasche et al. Sep 2008 B2
7440538 Tsujii Oct 2008 B2
7467007 Lothert Dec 2008 B2
7474913 Durlak Jan 2009 B2
7502503 Bojer et al. Mar 2009 B2
7505549 Ohishi et al. Mar 2009 B2
7508388 Barfuss et al. Mar 2009 B2
7551759 Hristov et al. Jun 2009 B2
7603155 Jensen et al. Oct 2009 B2
7620223 Xu et al. Nov 2009 B2
7639866 Pomero et al. Dec 2009 B2
7664542 Boese et al. Feb 2010 B2
7671887 Pescatore et al. Mar 2010 B2
7689019 Boese et al. Mar 2010 B2
7689042 Brunner et al. Mar 2010 B2
7693263 Bouvier et al. Apr 2010 B2
7711082 Fujimoto et al. May 2010 B2
7711083 Heigl et al. May 2010 B2
7711409 Keppel et al. May 2010 B2
7712961 Horndler et al. May 2010 B2
7720520 P et al. May 2010 B2
7725165 Chen et al. May 2010 B2
7734329 Boese et al. Jun 2010 B2
7742557 Brunner et al. Jun 2010 B2
7761135 Pfister et al. Jul 2010 B2
7778685 Evron et al. Aug 2010 B2
7778690 Boese et al. Aug 2010 B2
7787932 Vilsmeier et al. Aug 2010 B2
7804991 Abovitz et al. Sep 2010 B2
7831096 Williamson et al. Nov 2010 B2
7835779 Anderson et al. Nov 2010 B2
7844094 Jeung et al. Nov 2010 B2
7853061 Gorges et al. Dec 2010 B2
7877132 Rongen et al. Jan 2011 B2
7899226 Pescatore et al. Mar 2011 B2
7907989 Borgert et al. Mar 2011 B2
7912180 Zou et al. Mar 2011 B2
7912262 Timmer et al. Mar 2011 B2
7916918 Suri et al. Mar 2011 B2
7949088 Nishide et al. May 2011 B2
7950849 Claus et al. May 2011 B2
7991450 Virtue et al. Aug 2011 B2
8000436 Seppi et al. Aug 2011 B2
8043003 Vogt et al. Oct 2011 B2
8045780 Boese et al. Oct 2011 B2
8050739 Eck et al. Nov 2011 B2
8090168 Washburn et al. Jan 2012 B2
8104958 Weiser et al. Jan 2012 B2
8111894 Haar Feb 2012 B2
8111895 Spahn Feb 2012 B2
8126111 Uhde et al. Feb 2012 B2
8126241 Zarkh et al. Feb 2012 B2
8150131 Harer et al. Apr 2012 B2
8180132 Gorges et al. May 2012 B2
8195271 Rahn Jun 2012 B2
8200316 Keppel et al. Jun 2012 B2
8208708 Homan et al. Jun 2012 B2
8229061 Hanke et al. Jul 2012 B2
8248413 Gattani et al. Aug 2012 B2
8270691 Xu et al. Sep 2012 B2
8271068 Khamene et al. Sep 2012 B2
8275448 Camus et al. Sep 2012 B2
8306303 Bruder et al. Nov 2012 B2
8311617 Keppel et al. Nov 2012 B2
8320992 Frenkel et al. Nov 2012 B2
8326403 Pescatore et al. Dec 2012 B2
8335359 Fidrich et al. Dec 2012 B2
8340379 Razzaque et al. Dec 2012 B2
8345817 Fuchs et al. Jan 2013 B2
8374416 Gagesch et al. Feb 2013 B2
8374678 Graumann Feb 2013 B2
8423117 Pichon et al. Apr 2013 B2
8442618 Strommer et al. May 2013 B2
8482606 Razzaque et al. Jul 2013 B2
8515527 Vaillant et al. Aug 2013 B2
8526688 Groszmann et al. Sep 2013 B2
8526700 Isaacs Sep 2013 B2
8532258 Bulitta et al. Sep 2013 B2
8532259 Shedlock et al. Sep 2013 B2
8548567 Maschke et al. Oct 2013 B2
8625869 Harder et al. Jan 2014 B2
8666137 Nielsen et al. Mar 2014 B2
8670603 Tolkowsky et al. Mar 2014 B2
8675996 Liao et al. Mar 2014 B2
8693622 Graumann et al. Apr 2014 B2
8693756 Tolkowsky et al. Apr 2014 B2
8694075 Groszmann et al. Apr 2014 B2
8706184 Mohr et al. Apr 2014 B2
8706186 Fichtinger et al. Apr 2014 B2
8712129 Strommer et al. Apr 2014 B2
8718346 Isaacs et al. May 2014 B2
8750582 Boese et al. Jun 2014 B2
8755587 Bender et al. Jun 2014 B2
8781064 Fuchs et al. Jul 2014 B2
8792704 Isaacs Jul 2014 B2
8798339 Mielekamp et al. Aug 2014 B2
8827934 Chopra et al. Sep 2014 B2
8831310 Razzaque et al. Sep 2014 B2
8855748 Keppel et al. Oct 2014 B2
9001121 Finlayson et al. Apr 2015 B2
9001962 Funk Apr 2015 B2
9008367 Tolkowsky et al. Apr 2015 B2
9031188 Belcher et al. May 2015 B2
9036777 Ohishi et al. May 2015 B2
9042624 Dennerlein May 2015 B2
9044190 Rubner et al. Jun 2015 B2
9087404 Hansis et al. Jul 2015 B2
9095252 Popovic Aug 2015 B2
9104902 Xu et al. Aug 2015 B2
9111175 Strommer et al. Aug 2015 B2
9135706 Zagorchev et al. Sep 2015 B2
9171365 Mareachen et al. Oct 2015 B2
9179878 Jeon Nov 2015 B2
9216065 Cohen et al. Dec 2015 B2
9232924 Liu et al. Jan 2016 B2
9262830 Bakker et al. Feb 2016 B2
9265468 Rai et al. Feb 2016 B2
9277893 Tsukagoshi et al. Mar 2016 B2
9280837 Grass et al. Mar 2016 B2
9282944 Fallavollita et al. Mar 2016 B2
9375268 Long Jun 2016 B2
9401047 Bogoni et al. Jul 2016 B2
9406134 Klingenbeck-Regn et al. Aug 2016 B2
9433390 Nathaniel et al. Sep 2016 B2
9445772 Callaghan et al. Sep 2016 B2
9445776 Han et al. Sep 2016 B2
9466135 Koehler et al. Oct 2016 B2
9743896 Averbuch Aug 2017 B2
9833167 Cohen et al. Dec 2017 B2
9888898 Imagawa et al. Feb 2018 B2
9918659 Chopra et al. Mar 2018 B2
10004558 Long et al. Jun 2018 B2
10127629 Razzaque et al. Nov 2018 B2
10130316 Funabasama et al. Nov 2018 B2
10194897 Cedro et al. Feb 2019 B2
10373719 Soper et al. Aug 2019 B2
10376178 Chopra Aug 2019 B2
10405753 Sorger Sep 2019 B2
10478162 Barbagli et al. Nov 2019 B2
10480926 Froggatt et al. Nov 2019 B2
10524866 Srinivasan et al. Jan 2020 B2
10555788 Panescu et al. Feb 2020 B2
10569071 Harris et al. Feb 2020 B2
10603106 Weide et al. Mar 2020 B2
10610306 Chopra Apr 2020 B2
10638953 Duindam et al. May 2020 B2
10639114 Schuh et al. May 2020 B2
10674970 Averbuch et al. Jun 2020 B2
10682070 Duindam Jun 2020 B2
10702137 Deyanov Jul 2020 B2
10706543 Donhowe et al. Jul 2020 B2
10709506 Coste-Maniere et al. Jul 2020 B2
10772485 Schlesinger et al. Sep 2020 B2
10796432 Mintz et al. Oct 2020 B2
10823627 Sanborn et al. Nov 2020 B2
10827913 Ummalaneni et al. Nov 2020 B2
10835153 Rafii-Tari et al. Nov 2020 B2
10885630 Li et al. Jan 2021 B2
10896506 Zhao et al. Jan 2021 B2
20020122536 Kerrien et al. Sep 2002 A1
20020147462 Mair et al. Oct 2002 A1
20020163996 Kerrien et al. Nov 2002 A1
20020188194 Cosman Dec 2002 A1
20030013972 Makin Jan 2003 A1
20030088179 Seeley et al. May 2003 A1
20040120981 Nathan Jun 2004 A1
20050220264 Homegger Oct 2005 A1
20050245807 Boese et al. Nov 2005 A1
20050281385 Johnson Dec 2005 A1
20060182216 Lauritsch et al. Aug 2006 A1
20060251213 Bernhardt et al. Nov 2006 A1
20070276216 Beyar et al. Nov 2007 A1
20080045938 Weide et al. Feb 2008 A1
20090080765 Bernard et al. Mar 2009 A1
20090163800 Xu Jun 2009 A1
20130231556 Housing Sep 2013 A1
20130303945 Blumenkranz et al. Nov 2013 A1
20140035798 Kawada et al. Feb 2014 A1
20140046175 Ladtkow et al. Feb 2014 A1
20140232840 Housing Aug 2014 A1
20140281961 Baker Sep 2014 A1
20140343408 Tolkowsky Nov 2014 A1
20150148690 Chopra et al. May 2015 A1
20150223902 Walker Aug 2015 A1
20150227679 Kamer et al. Aug 2015 A1
20150265368 Chopra et al. Sep 2015 A1
20150320513 Yoon Nov 2015 A1
20150342546 Zaiki Dec 2015 A1
20160000302 Brown Jan 2016 A1
20160005194 Schretter et al. Jan 2016 A1
20160120521 Weingarten May 2016 A1
20160157939 Larkin et al. Jun 2016 A1
20160183841 Duindam et al. Jun 2016 A1
20160192860 Allenby et al. Jul 2016 A1
20160206380 Sparks et al. Jul 2016 A1
20160287343 Eichler et al. Oct 2016 A1
20160287344 Donhowe et al. Oct 2016 A1
20160302747 Averbuch Oct 2016 A1
20170035379 Weingarten et al. Feb 2017 A1
20170035380 Barak et al. Feb 2017 A1
20170112571 Thiel et al. Apr 2017 A1
20170112576 Coste-Maniere et al. Apr 2017 A1
20170151027 Walker Jun 2017 A1
20170209071 Zhao et al. Jul 2017 A1
20170265952 Donhowe et al. Sep 2017 A1
20170311844 Zhao et al. Nov 2017 A1
20170319165 Averbuch Nov 2017 A1
20180078318 Barbagli et al. Mar 2018 A1
20180144092 Flitsch et al. May 2018 A1
20180153621 Duindam et al. Jun 2018 A1
20180160991 Chun et al. Jun 2018 A1
20180235709 Donhowe et al. Aug 2018 A1
20180240237 Donhowe et al. Aug 2018 A1
20180256262 Duindam et al. Sep 2018 A1
20180263706 Averbuch Sep 2018 A1
20180279852 Rafii-Tari et al. Oct 2018 A1
20180310907 Zhang Nov 2018 A1
20180325419 Zhao et al. Nov 2018 A1
20190000559 Berman et al. Jan 2019 A1
20190000560 Berman et al. Jan 2019 A1
20190005687 Weingarten et al. Jan 2019 A1
20190008413 Duindam et al. Jan 2019 A1
20190038365 Soper Feb 2019 A1
20190065209 Mishra et al. Feb 2019 A1
20190110839 Rafii-Tari et al. Apr 2019 A1
20190142528 Vertikov May 2019 A1
20190175062 Rafii-Tari et al. Jun 2019 A1
20190175799 Hsu et al. Jun 2019 A1
20190183318 Froggatt et al. Jun 2019 A1
20190183585 Rafii-Tari et al. Jun 2019 A1
20190183587 Rafii-Tari et al. Jun 2019 A1
20190192234 Gadda et al. Jun 2019 A1
20190209016 Herzlinger et al. Jul 2019 A1
20190209043 Zhao et al. Jul 2019 A1
20190216548 Ummalaneni Jul 2019 A1
20190239723 Duindam et al. Aug 2019 A1
20190239831 Chopra Aug 2019 A1
20190250050 Sanborn et al. Aug 2019 A1
20190254649 Walters et al. Aug 2019 A1
20190269470 Barbagli et al. Sep 2019 A1
20190269818 Dhanaraj et al. Sep 2019 A1
20190269819 Dhanaraj et al. Sep 2019 A1
20190272634 Li et al. Sep 2019 A1
20190298160 Ummalaneni et al. Oct 2019 A1
20190298451 Wong et al. Oct 2019 A1
20190320878 Duindam et al. Oct 2019 A1
20190320937 Duindam et al. Oct 2019 A1
20190336238 Yu et al. Nov 2019 A1
20190343424 Blumenkranz et al. Nov 2019 A1
20190350659 Wang et al. Nov 2019 A1
20190365199 Zhao et al. Dec 2019 A1
20190365479 Rafii-Tari Dec 2019 A1
20190365486 Srinivasan et al. Dec 2019 A1
20190380787 Ye et al. Dec 2019 A1
20200000319 Saadat et al. Jan 2020 A1
20200000526 Zhao Jan 2020 A1
20200008655 Schlesinger et al. Jan 2020 A1
20200030044 Wang et al. Jan 2020 A1
20200030461 Sorger Jan 2020 A1
20200038750 Kojima Feb 2020 A1
20200043207 Lo et al. Feb 2020 A1
20200046431 Soper et al. Feb 2020 A1
20200046436 Tzeisler et al. Feb 2020 A1
20200054399 Duindam et al. Feb 2020 A1
20200054408 Schuh et al. Feb 2020 A1
20200060771 Lo et al. Feb 2020 A1
20200069192 Sanborn et al. Mar 2020 A1
20200077870 Dicarlo et al. Mar 2020 A1
20200078023 Cedro et al. Mar 2020 A1
20200078095 Chopra et al. Mar 2020 A1
20200078103 Duindam et al. Mar 2020 A1
20200085514 Blumenkranz Mar 2020 A1
20200109124 Pomper et al. Apr 2020 A1
20200129045 Prisco Apr 2020 A1
20200129239 Bianchi et al. Apr 2020 A1
20200138514 Blumenkranz et al. May 2020 A1
20200138515 Wong May 2020 A1
20200142013 Wong May 2020 A1
20200155116 Donhowe et al. May 2020 A1
20200155232 Wong May 2020 A1
20200170623 Averbuch Jun 2020 A1
20200170720 Ummalaneni Jun 2020 A1
20200179058 Barbagli et al. Jun 2020 A1
20200188021 Wong et al. Jun 2020 A1
20200188038 Donhowe et al. Jun 2020 A1
20200205903 Srinivasan et al. Jul 2020 A1
20200205904 Chopra Jul 2020 A1
20200214664 Zhao et al. Jul 2020 A1
20200229679 Zhao et al. Jul 2020 A1
20200242767 Zhao et al. Jul 2020 A1
20200275860 Duindam Sep 2020 A1
20200297442 Adebar et al. Sep 2020 A1
20200315554 Averbuch et al. Oct 2020 A1
20200330795 Sawant et al. Oct 2020 A1
20200352427 Deyanov Nov 2020 A1
20200364865 Donhowe et al. Nov 2020 A1
20200383750 Kemp et al. Dec 2020 A1
20210000524 Barry et al. Jan 2021 A1
20210192759 Lang Jun 2021 A1
Foreign Referenced Citations (42)
Number Date Country
0013237 Jul 2003 BR
0116004 Jun 2004 BR
0307259 Dec 2004 BR
0412298 Sep 2006 BR
112018003862 Oct 2018 BR
101190149 Jun 2008 CN
1644519 Dec 2008 CZ
486540 Sep 2016 CZ
2709512 Aug 2017 CZ
2884879 Jan 2020 CZ
19919907 Nov 2000 DE
69726415 Sep 2004 DE
102004004620 Aug 2005 DE
0917855 May 1999 EP
1593343 Nov 2005 EP
1644519 Dec 2008 EP
2141497 Jan 2010 EP
3413830 Sep 2019 EP
3478161 Feb 2020 EP
3641686 Apr 2020 EP
3644885 May 2020 EP
3644886 May 2020 EP
3749239 Dec 2020 EP
PA03005028 Jan 2004 MX
PA03000137 Sep 2004 MX
PA03006874 Sep 2004 MX
225663 Jan 2005 MX
226292 Feb 2005 MX
PA03010507 Jul 2005 MX
PA05011725 May 2006 MX
06011286 Mar 2007 MX
246862 Jun 2007 MX
2007006441 Aug 2007 MX
265247 Mar 2009 MX
284569 Mar 2011 MX
9944503 Sep 1999 WO
0187136 Nov 2001 WO
2004081877 Sep 2004 WO
2005015125 Feb 2005 WO
2005082246 Sep 2005 WO
2009081297 Jul 2009 WO
2015101948 Jul 2015 WO
Non-Patent Literature Citations (8)
Entry
“Image-Based Bronchoscopy Navigation System Based on CT and C-arm Fluoroscopy”, Big Data Analytics in the Social and Ubiquitous Context : 5th International Workshop on Modeling Social Media, MSM 2014, 5th International Workshop on Mining Ubiquitous and Social Environments, Muse 2014 and First International Workshop on Machine LE, No. 558, Mar. 29, 2014 (Mar. 29, 2014).
Extended European Search Report issued in European Application No. 18865691.2 dated Jul. 21, 2021, 11 pages.
Steenbeke Femke et al: “Analysis of the targeting uncertainty of a stereotactic frameless radiosurgery technique for arteriovenous malformation; incl. Supplementary data” Radiotherapy and Oncology, Elsevier, Ireland, vol. 113, No. 3, Dec. 1, 2014 (Dec. 1, 2014), pp. 371-373.
Australian Examination Report No. 2 issued in Appl. No. AU 2016210747 dated Oct. 18, 2017 (4 pages).
Canadian Office Action issued in Appl. No. 2,937,825 dated Mar. 26, 2018 (4 pages).
CT scan—Wikipedia, the free encyclopedia [retrieved from internet on Mar. 30, 2017], published on Jun. 30, 2015 as per Wayback Machine.
Extended European Search Report from Appl. No. EP 16182953.6-1666 dated Jan. 2, 2017.
Office Action issued in Chinese Appl. No. 201610635896.X dated Jul. 23, 2018, together with English language translation (16 pages).
Related Publications (1)
Number Date Country
20210085274 A1 Mar 2021 US
Provisional Applications (3)
Number Date Country
62641777 Mar 2018 US
62628017 Feb 2018 US
62570431 Oct 2017 US
Continuations (1)
Number Date Country
Parent 16156650 Oct 2018 US
Child 17115599 US